Skip to content

Effects of remidazolam anesthesia and total propofol on the quality of postoperative recovery in patients undergoing laparoscopic surgery 30 minutes before surgery: a randomized controlled trial

Effect of total anesthesia with rimazole or propofol on stress response during extubation in patients undergoing intubation general anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070005
Enrollment
Unknown
Registered
2023-03-31
Start date
2023-04-01
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recovery quality of general anesthesia

Interventions

Remazolam group:Remazolam toluenesulfonate 0.3~1.0 mg/kg/h maintenance anesthesia
Propofol group :Propofol 4-6 mg/kg/h for maintenance anesthesia

Sponsors

Affiliated Hospital of Guangdong Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. All patients had indications for laparoscopic surgery and anesthesia; 2. American Association of anesthesiologists (ASA) grade: Grade I-II; 3. It can complete the observation of various indexes before and after operation; 4. Aged 30-60 years; 5. Patients' informed consent to the study.

Exclusion criteria

Exclusion criteria: 1. Patients with serious cardiovascular and cerebrovascular diseases; 2. Unable to tolerate laparoscopic surgery or serious postoperative complications; 3. Allergic to narcotic drugs used in this study; 4. Patients with long-term use of narcotic analgesics, sedatives or non steroidal anti-inflammatory drugs; 5. Opioid dependent or opioid tolerant; 6. Patients with systemic hypotension despite the use of vasoactive drugs; 7. Bradycardia, heart rate < 55 beats/min; 8. High atrioventricular block without pacemaker; 9. Complicated with craniocerebral injury and intracranial hypertension; 10. Patients with severe cardiac, pulmonary, liver and renal dysfunction; 11. Previous allergic disease history; 12. Previous mental disease history; 13. Fat metabolism disorder; 14. Predictably difficult intubation; 15. The investigator judged that the subject was not suitable to participate in the clinical trial and was unable to cooperate to complete the study.

Design outcomes

Primary

MeasureTime frame
Awakening quality score;Extubation time;

Secondary

MeasureTime frame
Respiratory recovery time;Adverse reactions after surgery;

Countries

China

Contacts

Public ContactGu Xiaoxia

Affiliated Hospital of Guangdong Medical University

343251863@qq.com+86 137 2903 0217

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026